Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

cyclopia sequence 10Lung Neoplasms 3Pain 2Neoplasms, Plasma Cell 2Multiple Myeloma 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Sleepiness 1Peripheral Nervous System Diseases 1Parasomnias 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Laryngeal Diseases 1Hypesthesia 1Glioma 1Fatigue 1Exanthema 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Carcinoma 1Anxiety Disorders 1Anorexia 1Acute Pain 1

Interventions

Bevacizumab 112Fluorouracil 98Oxaliplatin 96Leucovorin 96Irinotecan 86Capecitabine 73Cetuximab 64Panitumumab 42pembrolizumab 39regorafenib 28Nivolumab 23IFL protocol 22Folfox protocol 21trifluridine tipiracil drug combination 14Radiotherapy 13durvalumab 11Gemcitabine 10Celecoxib 10tremelimumab 7binimetinib 7aflibercept 7Drug Therapy 7Disulfides 7Cyclophosphamide 7Trifluridine 6Trastuzumab 6Sunitinib 6Paclitaxel 6Immunoglobulin G 6Colonoscopy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Colorectal Neoplasms × Minocycline × Clear all
NCT01906008 2020-03-17

Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients

M.D. Anderson Cancer Center

Phase 2 Completed
122 enrolled 9 charts
Gastrointestinal

cyclopia sequence, Hypesthesia, Pain, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡